Category: Funding Roundup
USGI Medical says it raised $19.5 million in new debt and equity financing to fuel international commercial plans and U.S. regulatory efforts for its endoscopic weight-loss device.
California's USGI Medical said it raised $19.5 million in new equity and debt financing designed, in part, to back the final stages of the U.S. approval process for an incision-less endoscopic weight-loss procedure known as POSE.
Here's a look at some of the top legal news stories for medical device companies this week: VCs put more into fewer medtech deals last year; Samsung leads $20m round for EarlySense; K2M registers for $40m follow-on
K2M Group registers for a $40 million follow-on offering of nearly 5 million shares and wins a nod from the FDA for a new spinal implant.
K2M Group (NSDQ:KTWO) said it registered for a $40 million follow-on public offering and won a nod from the FDA for a new spinal implant system.
The collective value of venture capital investments in medical device companies surged last year even as deal volumes were flat, according to the MoneyTree report.
Venture capitalists put more cash into fewer deals backing medical device companies last year, according to the MoneyTree report, meaning that the average deal value rose nearly 28% in 2014.
EarlySense, a medical monitoring company based in Massachusetts and Israel, attracted $20 million in new financing from Samsung and others.
A new report on venture capital investment by research firm CB Insights says deal flow in medtech topped all of healthcare in 2014.
It was a very good year for venture capital investment in the medical device industry, according to research firm CB Insights.
Vascular Dynamics secures a $17 million Series B round to fund clinical trials for its device to treat drug-resistant hypertension.
Vascular Dynamics said it secured $16.85 million in Series B financing to fund clinical trials for its device to treat drug-resistant hypertension.